Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ohlmann

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Biochemical Pharmacology|July 15, 1990
The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb-IIIa complex in rat and in manC Gachet, A Stierlé, J P Cazenave, et al.
International Journal of Cardiology|May 31, 2014
Mitral valve surgery for transient severe mitral regurgitation: an alternative to medical treatment?N Messas, H Samet, J Brocchi, et al.
Biochemical Pharmacology|December 15, 1990
The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1C Gachet, J P Cazenave, P Ohlmann, et al.
The Biochemical Journal|December 15, 1995
The human platelet ADP receptor activates Gi2 proteinsP Ohlmann, K L Laugwitz, B Nürnberg, et al.
The Journal of Investigative Dermatology|November 1, 1991
Ultrastructural similarities between epidermal Langerhans cell Birbeck granules and the surface-connected canalicular system of EDTA-treated human blood plateletsD Hanau, C Gachet, D A Schmitt, et al.
Haemostasis|January 1, 1992
Electrophoretic studies on molecular defects of von Willebrand factor and platelet glycoprotein IIb-IIIa with antibodies produced in egg yolk from laying hensF Toti, C Gachet, P Ohlmann, et al.
Fundamental & Clinical Pharmacology|February 24, 2001
Effect of lipopolysaccharide treatment on neurogenic contraction and noradrenaline release in rat arteriesP Ohlmann, M C Martínez, B Bucher, et al.
Annales De Cardiologie Et D'Angeiologie|May 17, 2011
[Usefulness of diastolic deceleration time assessed by transthoracic Doppler measurement in the detection of sustained microvascular obstruction in STEMI patients treated by primary PTCA]M Messas, A Trinh, L Jesel, et al.
FEBS Letters|September 22, 2001
The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin--a phosphoinositide 3-kinase-dependent mechanismG Kauffenstein, W Bergmeier, A Eckly, et al.
Thrombosis and Haemostasis|May 1, 1997
Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 productionM Cattaneo, R Lombardi, M L Zighetti, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Biochemical Pharmacology|July 15, 1990
The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb-IIIa complex in rat and in manC Gachet, A Stierlé, J P Cazenave, et al.
International Journal of Cardiology|May 31, 2014
Mitral valve surgery for transient severe mitral regurgitation: an alternative to medical treatment?N Messas, H Samet, J Brocchi, et al.
Biochemical Pharmacology|December 15, 1990
The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1C Gachet, J P Cazenave, P Ohlmann, et al.
The Biochemical Journal|December 15, 1995
The human platelet ADP receptor activates Gi2 proteinsP Ohlmann, K L Laugwitz, B Nürnberg, et al.
The Journal of Investigative Dermatology|November 1, 1991
Ultrastructural similarities between epidermal Langerhans cell Birbeck granules and the surface-connected canalicular system of EDTA-treated human blood plateletsD Hanau, C Gachet, D A Schmitt, et al.
Haemostasis|January 1, 1992
Electrophoretic studies on molecular defects of von Willebrand factor and platelet glycoprotein IIb-IIIa with antibodies produced in egg yolk from laying hensF Toti, C Gachet, P Ohlmann, et al.
Fundamental & Clinical Pharmacology|February 24, 2001
Effect of lipopolysaccharide treatment on neurogenic contraction and noradrenaline release in rat arteriesP Ohlmann, M C Martínez, B Bucher, et al.
Annales De Cardiologie Et D'Angeiologie|May 17, 2011
[Usefulness of diastolic deceleration time assessed by transthoracic Doppler measurement in the detection of sustained microvascular obstruction in STEMI patients treated by primary PTCA]M Messas, A Trinh, L Jesel, et al.
FEBS Letters|September 22, 2001
The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin--a phosphoinositide 3-kinase-dependent mechanismG Kauffenstein, W Bergmeier, A Eckly, et al.
Thrombosis and Haemostasis|May 1, 1997
Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 productionM Cattaneo, R Lombardi, M L Zighetti, et al.
Pageof 7